{"id":32843,"date":"2022-07-25T11:43:20","date_gmt":"2022-07-25T17:43:20","guid":{"rendered":"https:\/\/somagen.com\/aps\/"},"modified":"2024-01-24T14:04:21","modified_gmt":"2024-01-24T21:04:21","slug":"aps","status":"publish","type":"page","link":"https:\/\/www.somagen.com\/fr\/aps\/","title":{"rendered":"APS"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Syndrome des antiphospholipides (SAPL)\u00a0<\/strong><\/h3>

Le syndrome des antiphospholipides (SAPL) est une condition \u00e9mergente qui peut sous-tendre plus d\u2019affections de ce qui a \u00e9t\u00e9 per\u00e7u au d\u00e9part. Les divers sympt\u00f4mes du SAPL comprennent la thrombose veineuse profonde des membres inf\u00e9rieurs, l\u2019embolie pulmonaire, les fausses couches pr\u00e9coces et tardives, les troubles de la m\u00e9moire, les caract\u00e9ristiques cliniques de l\u2019arthrite, le livedo reticularis, la migraine, ou l\u2019\u00e9pilepsie.1,2<\/sup> C\u2019est une maladie auto-immune syst\u00e9mique dans laquelle les anticorps sont dirig\u00e9s contre les complexes phospholipidiques-prot\u00e9iques.3<\/sup><\/p>

Le SAPL est plus courant chez les femmes que chez les hommes dans un ratio d\u2019environ 5:1. Bien que l\u2019\u00e2ge moyen d\u2019apparition des manifestations cliniques ait tendance \u00e0 se situer dans la tranche d\u2019\u00e2ge moyenne, le SAPL peut aussi se manifester chez les enfants et les patients plus \u00e2g\u00e9s. Le SAPL semble mener directement \u00e0 une combinaison de sympt\u00f4mes. Les maux de t\u00eate \u2014 en particulier les migraines \u2014 qui remontent \u00e0 l\u2019enfance et ont souvent des ant\u00e9c\u00e9dents familiaux qui peuvent \u00eatre un signe pr\u00e9coce de SAPL.2<\/sup><\/p>

Apprenez-en plus<\/a><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tAcc\u00e9dez le catalogue complet <\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tR\u00e9f\u00e9rences<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t
    \r\n \t
  1. Sciascia S, Baldovino S, Schreiber K, et al. Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay.\u00a0Clin Mol Allergy.<\/i>\u00a02016:14:6.<\/li>\r\n \t
  2. Hughes RV. Put Hughes Syndrome on Your Radar. The Rhematologist. 2007. http:\/\/www.the-rheumatologist.org\/article\/put-hughes-syndrome-on-your-radar\/. Accessed November 2017.<\/li>\r\n \t
  3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).\u00a0J Thromb Haemost.<\/i>\u00a02006;4:295-306.<\/li>\r\n \t
  4. Asherson RA, Cervera R. The antiphospholipid syndrome: multiple faces beyond the classical presentation.\u00a0Autoimmun Rev.<\/i>\u00a02003;2:140-151.<\/li>\r\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    Syndrome des antiphospholipides (SAPL)\u00a0 Le syndrome des antiphospholipides (SAPL) est une condition \u00e9mergente qui peut sous-tendre plus d\u2019affections de ce qui a \u00e9t\u00e9 per\u00e7u au d\u00e9part. Les divers sympt\u00f4mes du […]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"class_list":["post-32843","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.somagen.com\/fr\/wp-json\/wp\/v2\/pages\/32843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.somagen.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.somagen.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.somagen.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.somagen.com\/fr\/wp-json\/wp\/v2\/comments?post=32843"}],"version-history":[{"count":8,"href":"https:\/\/www.somagen.com\/fr\/wp-json\/wp\/v2\/pages\/32843\/revisions"}],"predecessor-version":[{"id":42436,"href":"https:\/\/www.somagen.com\/fr\/wp-json\/wp\/v2\/pages\/32843\/revisions\/42436"}],"wp:attachment":[{"href":"https:\/\/www.somagen.com\/fr\/wp-json\/wp\/v2\/media?parent=32843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}